Category Archives: ACR Appropriateness Criteria

Linking To And Excerpting From CoreIM’s “ILD and High-Risk Medication Prescribing: Gray Matters Segment”

In addition to today’s resource, please review  ACR Appropriateness Criteria® Diffuse Lung Disease, Volume 18, Issue 11, Supplement S320-S329November 2021: Abstract Diffuse lung disease, frequently referred to as interstitial lung disease, encompasses numerous disorders affecting the lung parenchyma. The potential etiologies of diffuse … Continue reading

Posted in ACR Appropriateness Criteria, CoreIM, Interstitial Lung Disease, Pulmonology | Comments Off on Linking To And Excerpting From CoreIM’s “ILD and High-Risk Medication Prescribing: Gray Matters Segment”